Literature DB >> 7947554

Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy.

B Patel1, P Hiscott, D Charteris, J Mather, D McLeod, M Boulton.   

Abstract

A number of growth factors have been implicated in the development and perpetuation of preretinal fibrovascular membranes in patients with proliferative diabetic retinopathy (PDR). The aim of this study was to determine the potential role of epidermal growth factor (EGF), transforming growth factor alpha (TGF-alpha), and their receptor (EGF-R) in PDR development. Immunostaining for EGF, TGF-alpha, and EGF-R was compared between normal retina, PDR retina, and PDR preretinal membranes. Weak staining for EGF and EGF-R was observed throughout the neural retina from non-diabetic eyes while weak to moderate staining for TGF-alpha was observed in the ganglion cell layer and the inner and outer nuclear layers. In contrast, intense staining for EGF and TGF-alpha and moderate staining for EGF-R were observed throughout the PDR retina. Immunoreactivity for EGF, TGF-alpha, and EGF-R was seen in the majority of the 11 excised membranes studied and, though variable, was generally greater than that observed in normal retinas. These results suggest an autocrine/paracrine role for EGF, TGF-alpha, and EGF-R in PDR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947554      PMCID: PMC504912          DOI: 10.1136/bjo.78.9.714

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

Review 1.  Growth factors in the eye.

Authors:  J W McAvoy; C G Chamberlain
Journal:  Prog Growth Factor Res       Date:  1990

2.  Cultured Müller cells have high levels of epidermal growth factor receptors.

Authors:  R S Roque; R B Caldwell; M A Behzadian
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-08       Impact factor: 4.799

3.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

Review 4.  Receptors for epidermal growth factor and other polypeptide mitogens.

Authors:  G Carpenter
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Presence of endothelial cell growth factor activity in normal and diabetic eyes.

Authors:  G A Lutty; C Chandler; A Bennett; C Fait; A Patz
Journal:  Curr Eye Res       Date:  1986-01       Impact factor: 2.424

6.  Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.

Authors:  M Grant; B Russell; C Fitzgerald; T J Merimee
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

Review 7.  Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects.

Authors:  M E Boulton; D McLeod; A Garner
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

8.  Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser; A Cardin; R G Michels
Journal:  Arch Ophthalmol       Date:  1985-09

9.  Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  A Sivalingam; J Kenney; G C Brown; W E Benson; L Donoso
Journal:  Arch Ophthalmol       Date:  1990-06

10.  Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  D Fredj-Reygrobellet; C Baudouin; F Nègre; J P Caruelle; P Gastaud; P Lapalus
Journal:  Ophthalmic Res       Date:  1991       Impact factor: 2.892

View more
  8 in total

1.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.

Authors:  M Boulton; Z Gregor; D McLeod; D Charteris; J Jarvis-Evans; P Moriarty; A Khaliq; D Foreman; D Allamby; B Bardsley
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

Review 2.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

3.  Growth factor staining patterns in the pig retina following retinal laser photocoagulation.

Authors:  M Xiao; D McLeod; J Cranley; G Williams; M Boulton
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

4.  Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.

Authors:  S M Wileman; N A Booth; N Moore; B Redmill; J V Forrester; R M Knott
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

5.  Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.

Authors:  Ibrahim F Benter; Mariam H M Yousif; Sioned M Griffiths; Mustapha Benboubetra; Saghir Akhtar
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Novel Biochemical Markers of Neurovascular Complications in Type 1 Diabetes Patients.

Authors:  Bogusz Falkowski; Anita Rogowicz-Frontczak; Ewelina Szczepanek-Parulska; Aleksandra Krygier; Elzbieta Wrotkowska; Aleksandra Uruska; Aleksandra Araszkiewicz; Marek Ruchala; Dorota Zozulinska-Ziolkiewicz
Journal:  J Clin Med       Date:  2020-01-10       Impact factor: 4.241

7.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

8.  Microfluidic generated EGF-gradients induce chemokinesis of transplantable retinal progenitor cells via the JAK/STAT and PI3kinase signaling pathways.

Authors:  Uchenna J Unachukwu; Moira Sauane; Maribel Vazquez; Stephen Redenti
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.